TLDR
- Cathie Wood’s ARK Invest acquired 97,597 shares of Baidu (BIDU) valued at $12.21 million following a 5.7% post-earnings decline
- Despite exceeding Q4 earnings and revenue forecasts, Baidu experienced a 4% year-over-year revenue decline due to advertising weakness
- ARK divested 25,175 shares of BWX Technologies (BWXT) worth $5.22 million as part of ongoing position reduction
- Additional sales included PagerDuty (PD), Beam Therapeutics (BEAM), Iridium (IRDM), Salesforce (CRM), and Butterfly Network (BFLY)
- AI-focused business units at Baidu contributed $1.61 billion in Q4 revenue, accounting for 43% of the company’s total
Cathie Wood’s investment firm, ARK Invest, executed a significant transaction on Thursday, February 26, acquiring shares in Chinese technology giant Baidu following a notable stock price retreat.
The investment manager accumulated 97,597 shares of Baidu (NASDAQ: BIDU) distributed across its flagship ARKK, ARKQ, and ARKW exchange-traded funds. The aggregate investment totaled $12.21 million.
This strategic purchase followed a 5.7% decline in Baidu’s stock price after the company disclosed its Q4 FY2025 financial results. While Baidu’s performance surpassed analyst expectations for both revenue and earnings, the market reacted negatively to a 4% annual revenue contraction.
The revenue shortfall stemmed primarily from continued struggles in Baidu’s traditional advertising segment, which has faced mounting challenges. These losses counterbalanced positive momentum in other divisions.
ARK’s investment strategy appears focused beyond the advertising headwinds. Company CEO Robin Li highlighted robust expansion in AI cloud services and increasing corporate adoption of Baidu’s artificial intelligence solutions.
During the fourth quarter, Baidu’s AI-driven operations — encompassing cloud infrastructure, AI applications, and autonomous taxi services — generated $1.61 billion in revenue. This figure represented 43% of the company’s quarterly total.
ARK Trims BWX Technologies and PagerDuty
Regarding divestments, ARK’s most substantial sale involved offloading 25,175 shares of nuclear components manufacturer BWX Technologies (NYSE: BWXT) for $5.22 million. This transaction extends ARK’s ongoing strategy of scaling back its BWXT holdings observed throughout the week.
The firm also liquidated 307,843 shares of cloud operations platform PagerDuty (NYSE: PD) for approximately $2.18 million. Interestingly, PD stock appreciated 5% on the trading day when ARK executed the sale.
The PagerDuty divestment reflects ARK’s consistent approach to decreasing exposure to this holding in recent weeks.
Additional disposals encompassed Beam Therapeutics (NASDAQ: BEAM), Iridium Communications (NASDAQ: IRDM), Salesforce (NYSE: CRM), Pinterest (NYSE: PINS), and Butterfly Network (NYSE: BFLY).
Biotech Buys and Other Moves
ARK simultaneously purchased 482,407 shares of biotechnology company ATAI Life Sciences (NASDAQ: ATAI) valued at approximately $1.79 million via its ARKG genomics fund.
ATAI shares declined 14.1% that same trading session, despite the company announcing favorable Phase IIa clinical trial results for EMP-01, its experimental treatment targeting social anxiety disorder.
Market analysts observed that while the trial outcomes demonstrated scientific promise, they weren’t sufficiently robust to validate ATAI’s previous valuation surge.
ARK additionally acquired 4,836 shares of Amazon (NASDAQ: AMZN) for $814,966 and 25,382 shares of Pure Storage (NYSE: PSTG) for $1.87 million.
According to TipRanks, BIDU maintains a Strong Buy consensus rating derived from seven Buy recommendations and two Hold ratings. The average analyst price target of $180.63 suggests potential upside of 44.3% from present levels.
BIDU shares have appreciated 41.8% during the past twelve months.
